# ADC Therapeutics (ADCT) — Overview

ADCT · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/adct

## Price

Last close $1.49 on Oct 15, 2026. 52-week range $0.96 – $4.88.

## Company profile

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $79.6M |
| Revenue (quarter) | $19.2M |
| Revenue growth (year over year) | 2.17% |
| Gross profit (trailing twelve months) | $70.7M |
| Gross margin | 88.86% |
| Net income (trailing twelve months) | −$96.9M |
| Net income (quarter) | −$16.6M |
| Net income growth (year over year) | 70.76% |
| Net margin | -121.77% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$0.58 |
| Book value per share | −$1.79 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 181.68% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is ADC Therapeutics (ADCT) profitable?

No. ADC Therapeutics reported a net loss of $96.9M over the trailing twelve months.

### How much revenue does ADC Therapeutics (ADCT) make?

ADC Therapeutics generated $79.6M in revenue over the trailing twelve months, up 2.17% year over year.

### How do I buy stock in ADC Therapeutics (ADCT)?

ADCT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).